Arctigenin from Saussurea medusa Maxim. Targets the PI3K/AKT Pathway to Inhibit Hepatocellular Carcinoma Proliferation and Induces Apoptosis
Nutrients · 2025
DOI: 10.3390/nu17193151 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, 2025. Verfasst von Ruitao Yu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Qinghai Provincial Key Laboratory of Tibetan Medicine Research, Northwest Institute of Plateau Biology, Chinese Academy of Sciences, Xining 810008, C…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Saussurea, Lignans. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Qinghai Province Central Government Guides Local Science and Technology Development Fund.
Abstract (Originalsprache)
Background
Hepatocellular carcinoma (HCC) is a highly lethal malignancy with limited therapeutic options. Arctigenin (ARC), a natural lignan derived from Saussurea medusa, exhibits anti-cancer activity, but its mechanism against HCC remain incompletely elucidated.
Methods
This study integrated network pharmacology, molecular docking, molecular dynamics, in vitro, and in vivo experiments to investigate ARC’s anti-HCC effects.
Results
Seventy-five potential targets shared between ARC and HCC were identified, with KEGG analysis highlighting the PI3K/AKT pathway as central. ARC showed strong binding to key proteins, and molecular dynamics indicated stable interactions with PIK3CA and GSK3B. In HepG2 cells, ARC inhibited proliferation in a dose- and time-dependent manner (IC50: 11.17 μM at 24 h, 4.888 μM at 48 h), induced apoptosis at high concentrations, suppressed PIK3CA phosphorylation, and increased GSK3B (Ser9) phosphorylation. In H22 tumor-bearing mice, ARC dose-dependently inhibited tumor growth (high dose: 50.6% vs. 63.0% for CTX) with minimal weight loss.
Conclusions
These findings suggest ARC suppresses HCC by modulating the PI3K/AKT pathway, providing evidence for its development as a plant-derived therapeutic agent.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Qinghai Provincial Key Laboratory of Tibetan Medicine Research, Northwest Institute of Plateau Biology, Chinese Academy of Sciences, Xining 810008, China.
- University of Chinese Academy of Sciences, Beijing 101408, China.
- School of Medicine, College of Pingdingshan University, Pingdingshan 467000, China.
ORCID-Profile: Ruixue Yu
Förderung
- Qinghai Province Central Government Guides Local Science and Technology Development Fund
Zitieren
APA
Yu, R., Chen, J., & Yu, R. (2025). Arctigenin from Saussurea medusa Maxim. Targets the PI3K/AKT Pathway to Inhibit Hepatocellular Carcinoma Proliferation and Induces Apoptosis. Nutrients. https://doi.org/10.3390/nu17193151
Vancouver
Yu R, Chen J, Yu R. Arctigenin from Saussurea medusa Maxim. Targets the PI3K/AKT Pathway to Inhibit Hepatocellular Carcinoma Proliferation and Induces Apoptosis. Nutrients. 2025. doi:10.3390/nu17193151
BibTeX
@article{Yu2025,
author = {Yu, Ruitao and Chen, Jinghua and Yu, Ruixue},
title = {Arctigenin from Saussurea medusa Maxim. Targets the PI3K/AKT Pathway to Inhibit Hepatocellular Carcinoma Proliferation and Induces Apoptosis},
journal = {Nutrients},
year = {2025},
doi = {10.3390/nu17193151}
}
EUVIMED